Quidel Corp (QDEL) Misses Q2 EPS by $1.09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
QuidelOrtho Reports Second Quarter 2022 Financial Results
August 4, 2022 4:10 PM EDTHighlights
Revenue of $613.4 million increased by 247% as reported; Supplemental combined revenue of $898.5 million increased by 37.5% in constant currency and 9.0%, excluding COVID-19 revenue Strong growth in all business units, excluding COVID-19 revenue, including double-digit growth in Point-of-Care and Molecular Diagnostics, and high-single-digit combined growth in Labs and Transfusion Medicine Strength across all major regions, including China, EMEA, and North America GAAP EPS of $0.36; Supplemental combined adjusted EPS of $2.12, a 123% increase from prior year, largely reflecting the strength of high margin COVID-19... More